CHN1 and diffuse large B-cell lymphoma: Couch et al. showed that CHN1 could be used as a biomarker for the diagnosis of esophageal squamous dysplasia and squamous cell cancer [27]; Sun et al., however, claimed that CHN1 could be used as a novel prognostic marker for diffuse large B-cell lymphoma [28].